InvestorsHub Logo
Followers 2
Posts 429
Boards Moderated 0
Alias Born 07/13/2016

Re: misiu143 post# 17025

Wednesday, 08/30/2017 5:38:20 PM

Wednesday, August 30, 2017 5:38:20 PM

Post# of 232939
I think the best you can hope for is they give PRO 140 the BTD and only require one phase III test for mono. There is no way the current phase III for mono will be cut short. PRO 140 might be good but it is not that good. This would only happen if there were not other therapies available for HIV patients but there are actually many. PRO 140 in mono will be quite a departure for the HIV community which is sold out to using three therapies. In most patients, those three therapies are working and there will be a reluctance to stop using something that is working as you can't really go back to an HIV medicine once you stop using it. Even if the patient wants to use PRO 140, their doctor will be initially reluctant to allow it. Since nobody will die if they don't rush PRO 140 to market, it will not be rushed.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News